BIOLOGICALLY ACTIVE COMPOUNDS AND COMPOSITIONS

The invention provides the use of a compound of the general formula (1 ) including stereoisomers thereof wherein R1 is R2 CO; and R2 -R6 are selected from H, lower alkyl, or lower alkenyl, in the manufacture of a medicament for the treatment of a microbial infection. The compound of formula (1 ) may...

Full description

Saved in:
Bibliographic Details
Main Authors GURLAL, PRENITHA, LAING, MARK, DELMEGE, DREWES, SIEGFRIED, E
Format Patent
LanguageEnglish
French
Published 03.01.2008
Online AccessGet full text

Cover

Abstract The invention provides the use of a compound of the general formula (1 ) including stereoisomers thereof wherein R1 is R2 CO; and R2 -R6 are selected from H, lower alkyl, or lower alkenyl, in the manufacture of a medicament for the treatment of a microbial infection. The compound of formula (1 ) may be obtained from a plant selected from Plectranthus hadiensis, Plectranthus argentatus and Plectranthus myrianthus. L'invention concerne l'utilisation d'un composé représenté par la formule générale (1) comprenant les stéréo-isomères de celui-ci, où R1 est R2CO ; et R2 -R6 sont choisis parmi H, alkyle inférieur ou alcényle inférieur, dans la fabrication d'un médicament pour le traitement d'une infection microbienne. Le composé représenté par la formule (1) peut être obtenu à partir d'une plante choisie parmi Plectranthus hadiensis, Plectranthus argentatus et Plectranthus myrianthus.
AbstractList The invention provides the use of a compound of the general formula (1 ) including stereoisomers thereof wherein R1 is R2 CO; and R2 -R6 are selected from H, lower alkyl, or lower alkenyl, in the manufacture of a medicament for the treatment of a microbial infection. The compound of formula (1 ) may be obtained from a plant selected from Plectranthus hadiensis, Plectranthus argentatus and Plectranthus myrianthus. L'invention concerne l'utilisation d'un composé représenté par la formule générale (1) comprenant les stéréo-isomères de celui-ci, où R1 est R2CO ; et R2 -R6 sont choisis parmi H, alkyle inférieur ou alcényle inférieur, dans la fabrication d'un médicament pour le traitement d'une infection microbienne. Le composé représenté par la formule (1) peut être obtenu à partir d'une plante choisie parmi Plectranthus hadiensis, Plectranthus argentatus et Plectranthus myrianthus.
Author GURLAL, PRENITHA
LAING, MARK, DELMEGE
DREWES, SIEGFRIED, E
Author_xml – fullname: GURLAL, PRENITHA
– fullname: LAING, MARK, DELMEGE
– fullname: DREWES, SIEGFRIED, E
BookMark eNrjYmDJy89L5WTQc_L09_F393R29PGJVHB0DvEMc1Vw9vcN8A_1cwlWcPRzgfCCPUM8_f2CeRhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGBhYGBoZG5haORMXGqAI9DKKU
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate COMPOSÉS BIOLOGIQUEMENT ACTIFS ET COMPOSITIONS
ExternalDocumentID WO2008001278A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2008001278A23
IEDL.DBID EVB
IngestDate Fri Jul 19 16:00:13 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2008001278A23
Notes Application Number: WO2007IB52375
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080103&DB=EPODOC&CC=WO&NR=2008001278A2
ParticipantIDs epo_espacenet_WO2008001278A2
PublicationCentury 2000
PublicationDate 20080103
PublicationDateYYYYMMDD 2008-01-03
PublicationDate_xml – month: 01
  year: 2008
  text: 20080103
  day: 03
PublicationDecade 2000
PublicationYear 2008
RelatedCompanies UNIVERSITY OF KWAZULU-NATAL
GURLAL, PRENITHA
LAING, MARK, DELMEGE
DREWES, SIEGFRIED, E
RelatedCompanies_xml – name: UNIVERSITY OF KWAZULU-NATAL
– name: DREWES, SIEGFRIED, E
– name: GURLAL, PRENITHA
– name: LAING, MARK, DELMEGE
Score 2.6892464
Snippet The invention provides the use of a compound of the general formula (1 ) including stereoisomers thereof wherein R1 is R2 CO; and R2 -R6 are selected from H,...
SourceID epo
SourceType Open Access Repository
Title BIOLOGICALLY ACTIVE COMPOUNDS AND COMPOSITIONS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20080103&DB=EPODOC&locale=&CC=WO&NR=2008001278A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUsCFnHGScm6hibJJrom5ilmuhbA_o6uoblhWkpSmqVxCmSVr5-ZR6iJV4RpBBNDDmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9Y4tQNcWqLk42boG-Lv4O6s5OwP7bWp-QRA50DSrhSOwwGYFNqTNQQvAXMOcQPtSCpArFTdBBrYAoHl5JUIMTKl5wgyczrC714QZOHyhU95AJjT3FYsw6Dl5wu4u8IlUAC3_CHNVcPb3DfAP9XMJVnD0c4Hwgj3Be4NFGZTdXEOcPXSBFsfD_Rkf7o_sSmMxBpa8_LxUCQaFVBPjVEtjy0QT86Qkk5RU80Rgu8nA0iDJ3CAJ2L0zNpNkkMFnkhR-aWkGLsgiCNDaKhkGlpKi0lRZYE1bkiQHDiAAPEF7_w
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1JS8NQEB5KFetNq2K1akDJLZqQZ5ZDkWYj0WzYtNZT6MsCgqTFRvz7TpJGe-rtLfA2mO3NNzMAdzlFFifShBNIQjgipxKnoL3DCbKQpzRXxbRB-fqSPSXP88d5Bz7bWJg6T-hPnRwRKSpBei9rfr36_8Qyamzl-oF-4NDyyYpGBttax0pVtoA1tJEZBkags7qOdhvrvzZzlZtVGSPD3kMlW6ky7ZszrYpLWW0LFesI9kNcryiPoZMVfejpbe21Phx4G5c3NjfUtz6Be81paxe470wF_5iZjB54YTD1jQkz9o2mN3Hq2OBTuLXMSLc53Dj-u2f8FmyfUjyDbrEssnNgMiJmqqguiEwpSTN5gXoTr_JU5imad6I0gOGulS52T99Az448N3Yd_-USDhtARIWzGkK3_PrOrlDqlvS6fqxfNMN-7w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=BIOLOGICALLY+ACTIVE+COMPOUNDS+AND+COMPOSITIONS&rft.inventor=GURLAL%2C+PRENITHA&rft.inventor=LAING%2C+MARK%2C+DELMEGE&rft.inventor=DREWES%2C+SIEGFRIED%2C+E&rft.date=2008-01-03&rft.externalDBID=A2&rft.externalDocID=WO2008001278A2